Rictor-targeting exosomal microRNA-16 ameliorates lung fibrosis by inhibiting the mTORC2-SPARC axis
Minoru Inomata, Koichiro Kamio, Arata Azuma, Kuniko Matsuda, Jiro Usuki, Akemi Morinaga, Toru Tanaka, Takeru Kashiwada, Kenichiro Atsumi, Hiroki Hayashi, Kazue Fujita, Yoshinobu Saito, Kaoru Kubota, Masahiro Seike, Akihiko Gemma
Topics & Concepts
BleomycinPulmonary fibrosismicroRNAIdiopathic pulmonary fibrosisBiologyFibrosisCancer researchExosomemTORC2LungMicrovesiclesPathologyPI3K/AKT/mTOR pathwayImmunologySignal transductionCell biologyMedicineInternal medicinemTORC1ChemotherapyGeneGeneticsBiochemistryInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisExtracellular vesicles in diseasePulmonary Hypertension Research and Treatments